Cargando…
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
BACKGROUND: The association of gadolinium-based contrast agents (GBCAs) with nephrogenic systemic fibrosis (NSF) has led to a heightened awareness towards patients’ renal function. Whereas detailed guidelines exist for the use of GBCAs in adult patients, best practice is less well defined in childre...
Autores principales: | Meng, Howard, Grosse-Wortmann, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492017/ https://www.ncbi.nlm.nih.gov/pubmed/22871150 http://dx.doi.org/10.1186/1532-429X-14-56 |
Ejemplares similares
-
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020) -
Moral Hazard in Health Insurance: What We Know and How We Know It
por: Einav, Liran, et al.
Publicado: (2018) -
The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)